Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Robert Schenken"'
Autor:
Sribalasubashini Muralimanoharan, Ross Shamby, Nicholas Stansbury, Robert Schenken, Barbara de la Pena Avalos, Samin Javanmardi, Eloise Dray, Patrick Sung, Thomas G. Boyer
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Uterine fibroid (UF) driver mutations in Mediator complex subunit 12 (MED12) trigger genomic instability and tumor development through unknown mechanisms. Herein, we show that MED12 mutations trigger aberrant R-loop-induced replication stres
Externí odkaz:
https://doaj.org/article/c0125838d6f34460b746424e73028e09
Autor:
Jennifer Knudtson, Jessica McLaughlin, Marlen Tellez Santos, Rajeshwar R Tekmal, Robert Schenken
Publikováno v:
Journal of Clinical and Translational Science, Vol 3, Pp 111-112 (2019)
OBJECTIVES/SPECIFIC AIMS: Previously, we showed decreased development of endometriotic lesions in CD44 knockout mice compared to control.(1) CD44 has 10 different variants and a standard form. Menstrual endometrial cells (MECs) from women with endome
Externí odkaz:
https://doaj.org/article/a6d28e5193c0459ca5206da524fbbe6a
Autor:
Jennifer Knudtson, Ya-Guang Liu, Marlen Tellez Santos, Rajeshwar Tekmal, Ratna Vadlamudi, Robert Schenken
Publikováno v:
Journal of Clinical and Translational Science, Vol 1, Pp 57-57 (2017)
OBJECTIVES/SPECIFIC AIMS: To further elucidate the role of estrogen receptor β (ER-β) in the early endometriotic lesion attachment. METHODS/STUDY POPULATION: EECs were immortalized using a telomerase vector. Immortalized cells and parental cells we
Externí odkaz:
https://doaj.org/article/b07a7e2b58124184ac0724bba8a4d8b4
Autor:
Jessica Campbell, Yumeng Huang, Yuanjun Liu, Robert Schenken, Bernard Arulanandam, Guangming Zhong
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e101634 (2014)
Chlamydial pathogenicity in the upper genital tract relies on chlamydial ascending from the lower genital tract. To monitor chlamydial ascension, we engineered a luciferase-expressing C. muridarum. In cells infected with the luciferase-expressing C.
Externí odkaz:
https://doaj.org/article/1fc1978a8a7b4c7c811229140714d735
Publikováno v:
Obstetrics & Gynecology. 141:25S-25S
Publikováno v:
Obstetrics & Gynecology. 141:99S-99S
Autor:
Subash Khadka, Claire Sun, Lindsey Barron, Robert Schenken, Nicholas Stansbury, Shin-Fu Chen, Kuang-Lei Tsai, Ron Firestein, Thomas Boyer
Publikováno v:
Journal of Biological Chemistry. 299:103415
Autor:
Rowan T. Chlebowski, Garnet L. Anderson, Margery Gass, Dorothy S. Lane, Aaron K. Aragaki, Lewis H. Kuller, JoAnn E. Manson, Marcia L. Stefanick, Judith Ockene, Gloria E. Sarto, Karen C. Johnson, Jean Wactawski-Wende, Peter M. Ravdin, Robert Schenken, Susan L. Hendrix, Aleksandar Rajkovic, Thomas E. Rohan, Shagufta Yasmeen, Ross L. Prentice, for the WHI Investigators
Context In the Women's Health Initiative randomized, placebo-controlled trial of estrogen plus progestin, after a mean intervention time of 5.6 (SD, 1.3) years (range, 3.7-8.6 years) and a mean follow-up of 7.9 (SD, 1.4) years, breast cancer incidenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8c343a5ec6066509d84080fbe94240b
https://europepmc.org/articles/PMC5142300/
https://europepmc.org/articles/PMC5142300/
Autor:
Rowan T, Chlebowski, Lewis H, Kuller, Ross L, Prentice, Marcia L, Stefanick, JoAnn E, Manson, Margery, Gass, Aaron K, Aragaki, Judith K, Ockene, Dorothy S, Lane, Gloria E, Sarto, Aleksandar, Rajkovic, Robert, Schenken, Susan L, Hendrix, Peter M, Ravdin, Thomas E, Rohan, Shagufta, Yasmeen, Garnet, Anderson, D, Bonds
Publikováno v:
The New England journal of medicine. 360(6)
Following the release of the 2002 report of the Women's Health Initiative (WHI) trial of estrogen plus progestin, the use of menopausal hormone therapy in the United States decreased substantially. Subsequently, the incidence of breast cancer also dr